✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-25

Lost Your Weight-Loss Coverage in 2026? How to Keep Your GLP-1 Therapy Going

If your insurance stopped covering your GLP-1 in 2026, you can usually continue treatment on a cash-pay basis without a gap. A self-pay clinic skips prior authorization, prices each step up front (semaglutide about $166 per month), and ships statewide by telehealth so therapy does not stall.

If your weight-loss medication coverage ended in 2026, you can usually keep your GLP-1 therapy going by switching to a cash-pay clinic. There is no prior authorization, no appeals, and no waiting on an insurer. A physician reviews your history, and you pay a flat, known price: compounded semaglutide runs about $166 per month, with a one-time $119 visit. The goal is continuity, not starting over.

Why coverage is disappearing in 2026, and what it means for you

Many people are losing GLP-1 coverage this year for reasons that have nothing to do with how well the medication worked for them. The common triggers are an employer switching to a plan that excludes weight-loss drugs, a formulary change that drops GLP-1s mid-year, and reductions in public coverage that have left some patients on Medicaid or marketplace plans without a covered option. Industry reporting through 2026 has documented a broad trend of plans tightening or removing weight-loss medication benefits, and some patients have also become hesitant to use coverage they technically still have.

For you, the practical issue is simpler: the prescription that was working is now unaffordable at the pharmacy counter, and you need a path that does not depend on an insurer's decision. That is exactly what cash-pay is built for. For a side-by-side look at how the two routes actually compare on cost and hassle, see our breakdown of cash-pay versus insurance for weight loss and our overview of whether insurance covers GLP-1 medication.

What continuity of care looks like when you switch to cash-pay

Continuity means picking up where you left off, not resetting to week one. When you transition to a cash-pay clinic, a licensed physician reviews your prior treatment so your care reflects what you have already done.

Ready to start?

$199 Skeptics' Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

It is important to be clear about what compounded medications are. They are prepared by licensed U.S. pharmacies, are not FDA-approved, and are not brand-identical to Ozempic, Wegovy, Mounjaro, or Zepbound. Results vary by individual. Our physician-supervised medical weight loss program is designed to keep that oversight in place during and after the switch.

What it costs, stated plainly

The single biggest reason therapy stalls after a coverage loss is uncertainty about cost. Our pricing is flat and posted up front, so you can do the math before you commit:

Medication is billed separately from the visit. For most patients losing coverage, the relevant comparison is not "free versus paid," it is the flat cash price here versus the much higher cash price of brand-name GLP-1s at a retail pharmacy. For a deeper look at the numbers, see how much semaglutide costs without insurance and our dedicated semaglutide program page.

How financing, HSA, and FSA keep the cost manageable

You have more options than paying everything at once. We accept HSA and FSA funds for physician-supervised medical weight loss, and we offer Klarna and Affirm so you can spread payments over time. That matters most in the first month after a coverage change, when a household budget is already adjusting. Keep your receipts and confirm your specific plan rules, since HSA and FSA administration varies by provider. Full details are on our financing and payment options page, and our guide to using HSA or FSA for weight loss walks through the eligibility questions patients ask most.

Telehealth, privacy, and bilingual care from home

You do not need to live near the clinic to keep your therapy going. We provide telehealth across California, so your visit and follow-ups happen from home and medication ships to you. Because we are cash-pay, no insurance is needed to be seen. Care is private and HIPAA-compliant, and our team works in both English and Spanish, so you can ask questions and manage your treatment in the language you are most comfortable in. For patients who lost coverage and simply want to keep going without paperwork or gatekeeping, this removes most of the friction.

The fastest way to avoid a gap in treatment

A lapse in GLP-1 therapy can mean losing momentum, so the priority is closing the gap quickly. The simplest next step is to take our 2-minute qualification quiz to confirm you are a candidate, then complete the $119 physician review. If you would rather test the fit first, the $199 Skeptics Trial gives you one month of compounded semaglutide with physician oversight before you commit to a longer plan. Start the quiz today, or call (657) 837-3342 to talk through continuing your therapy without insurance.

Start today, no insurance needed

Ready to keep physician-supervised GLP-1 care going without insurance? Take the free 2-minute quiz to see if you are a candidate, or start with the $199 Skeptics Trial.

Call (657) 837-3342

Frequently asked questions

I lost my GLP-1 coverage mid-treatment. Can I continue without restarting?

In most cases, yes. A licensed physician reviews your treatment history, including the dose you were on, so your care can continue rather than reset to week one. Compounded semaglutide and tirzepatide use the same active ingredients as the brand categories patients commonly start on. Compounded medications are not FDA-approved or brand-identical, and results vary by individual.

How much does it cost to continue semaglutide without insurance?

Compounded semaglutide is $499 for 90 days, which is about $166 per month, plus a one-time $119 physician visit. Compounded tirzepatide is $699 for 90 days, about $233 per month. A $199 Skeptics Trial covers one month of semaglutide if you want to confirm the fit first. Medication is billed separately from the visit.

Why did my plan stop covering weight-loss medication in 2026?

Common reasons include an employer switching to a plan that excludes weight-loss drugs, a mid-year formulary change that drops GLP-1s, and reductions in public coverage. Reporting through 2026 documents a broad trend of plans tightening these benefits. The reason rarely reflects how well the medication worked for you, which is why a cash-pay path can keep therapy going.

Do I need insurance to be seen at a cash-pay clinic?

No. The clinic is cash-pay, so no insurance is required to be seen or treated. You pay flat, posted prices directly, with no prior authorization, no appeals, and no insurer in the middle. HSA and FSA funds are accepted, and Klarna and Affirm financing are available to spread the cost while your budget adjusts after a coverage change.

Can I continue treatment from home if I do not live near the clinic?

Yes. We offer telehealth across California, so your visit and follow-up appointments happen from home and medication ships to you. Care is private and HIPAA-compliant, and our team works in both English and Spanish. This lets you continue GLP-1 therapy without travel, which is especially useful when you are trying to avoid a gap after losing coverage.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.